Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587882014> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2587882014 endingPage "285" @default.
- W2587882014 startingPage "279" @default.
- W2587882014 abstract "Purpose: Anthracyclines (ANTs) are a class of active antineoplastic agents with topoisomerase-interacting activity that are considered the most active agents for the treatment of breast cancer. We investigated the efficacy of carvedilol in the inhibition of ANT-induced cardiotoxicity. Methods: In this randomized, single-blind, placebo-controlled study, 91 women with recently diagnosed breast cancer undergoing ANT therapy were randomly assigned to groups treated with either carvedilol (n = 46) or placebo (n = 45). Echocardiography was performed before and at 6 months after randomization, and absolute changes in the mean left ventricular ejection fraction, left ventricular end diastolic volume, and left ventricular end systolic volume were determined. Furthermore, the percentage change in the left atrial (LA) diameter and other variables of left ventricular (LV) diastolic function, such as transmitral Doppler parameters, including early (E wave) and late (A wave) diastolic velocities, E/A ratio and E wave deceleration time, pulmonary venous Doppler signals, including forward systolic (S wave) and diastolic (D wave) velocities into LA, late diastolic atrial reversal velocity, and early diastolic tissue Doppler mitral annular velocity (e') were measured. In addition, tissue Doppler mitral annular systolic (s') velocity, as a marker of early stage of LV systolic dysfunction, E/e' ratio, as a determinant of LV filling pressure, and troponin I level, as a marker of myocardial necrosis were measured. Results: At the end of follow-up period, left ventricular ejection fraction did not change in the carvedilol group. However, this parameter was significantly reduced in the control group ( P < 0.001). Echocardiography showed that both left ventricular end systolic volume and LA diameter were significantly increased compared with the baseline measures in the control group. In pulse Doppler studies, pulmonary venous peak atrial reversal flow velocity was significantly increased in the control group. Moreover, a significant decrease in the mitral annuli early diastolic (e') and peak systolic (s') velocities and a significant increase in the E (the peak early diastolic velocity)/e' ratio in the control group were also observed. However, none of these variables were adversely changed at the end of follow-up in the carvedilol group. Furthermore, the TnI level was significantly higher in the control group than in the carvedilol group ( P = 0.036) at 30 days after the initiation of chemotherapy. Conclusions: Prophylactic use of carvedilol may inhibit the development of anthracycline-induced cardiotoxicity, even at low doses." @default.
- W2587882014 created "2017-02-24" @default.
- W2587882014 creator A5000953048 @default.
- W2587882014 creator A5030841698 @default.
- W2587882014 creator A5065799539 @default.
- W2587882014 creator A5072207850 @default.
- W2587882014 creator A5080631753 @default.
- W2587882014 date "2017-05-01" @default.
- W2587882014 modified "2023-10-01" @default.
- W2587882014 title "Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity" @default.
- W2587882014 cites W148860973 @default.
- W2587882014 cites W1980502996 @default.
- W2587882014 cites W1981345102 @default.
- W2587882014 cites W1984450750 @default.
- W2587882014 cites W1998141986 @default.
- W2587882014 cites W1999683906 @default.
- W2587882014 cites W2056137128 @default.
- W2587882014 cites W2112196039 @default.
- W2587882014 cites W2133304247 @default.
- W2587882014 cites W2156010010 @default.
- W2587882014 cites W2159853440 @default.
- W2587882014 cites W2160540392 @default.
- W2587882014 cites W2325996754 @default.
- W2587882014 cites W2546570677 @default.
- W2587882014 cites W3022179669 @default.
- W2587882014 doi "https://doi.org/10.1097/fjc.0000000000000470" @default.
- W2587882014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28141699" @default.
- W2587882014 hasPublicationYear "2017" @default.
- W2587882014 type Work @default.
- W2587882014 sameAs 2587882014 @default.
- W2587882014 citedByCount "64" @default.
- W2587882014 countsByYear W25878820142017 @default.
- W2587882014 countsByYear W25878820142018 @default.
- W2587882014 countsByYear W25878820142019 @default.
- W2587882014 countsByYear W25878820142020 @default.
- W2587882014 countsByYear W25878820142021 @default.
- W2587882014 countsByYear W25878820142022 @default.
- W2587882014 countsByYear W25878820142023 @default.
- W2587882014 crossrefType "journal-article" @default.
- W2587882014 hasAuthorship W2587882014A5000953048 @default.
- W2587882014 hasAuthorship W2587882014A5030841698 @default.
- W2587882014 hasAuthorship W2587882014A5065799539 @default.
- W2587882014 hasAuthorship W2587882014A5072207850 @default.
- W2587882014 hasAuthorship W2587882014A5080631753 @default.
- W2587882014 hasConcept C126322002 @default.
- W2587882014 hasConcept C142724271 @default.
- W2587882014 hasConcept C164705383 @default.
- W2587882014 hasConcept C204787440 @default.
- W2587882014 hasConcept C27081682 @default.
- W2587882014 hasConcept C2778198053 @default.
- W2587882014 hasConcept C2780346441 @default.
- W2587882014 hasConcept C2780591200 @default.
- W2587882014 hasConcept C57900726 @default.
- W2587882014 hasConcept C71924100 @default.
- W2587882014 hasConcept C78085059 @default.
- W2587882014 hasConcept C84393581 @default.
- W2587882014 hasConceptScore W2587882014C126322002 @default.
- W2587882014 hasConceptScore W2587882014C142724271 @default.
- W2587882014 hasConceptScore W2587882014C164705383 @default.
- W2587882014 hasConceptScore W2587882014C204787440 @default.
- W2587882014 hasConceptScore W2587882014C27081682 @default.
- W2587882014 hasConceptScore W2587882014C2778198053 @default.
- W2587882014 hasConceptScore W2587882014C2780346441 @default.
- W2587882014 hasConceptScore W2587882014C2780591200 @default.
- W2587882014 hasConceptScore W2587882014C57900726 @default.
- W2587882014 hasConceptScore W2587882014C71924100 @default.
- W2587882014 hasConceptScore W2587882014C78085059 @default.
- W2587882014 hasConceptScore W2587882014C84393581 @default.
- W2587882014 hasIssue "5" @default.
- W2587882014 hasLocation W25878820141 @default.
- W2587882014 hasLocation W25878820142 @default.
- W2587882014 hasOpenAccess W2587882014 @default.
- W2587882014 hasPrimaryLocation W25878820141 @default.
- W2587882014 hasRelatedWork W1949634191 @default.
- W2587882014 hasRelatedWork W1964205598 @default.
- W2587882014 hasRelatedWork W1998700507 @default.
- W2587882014 hasRelatedWork W2066491496 @default.
- W2587882014 hasRelatedWork W2167036398 @default.
- W2587882014 hasRelatedWork W2475222081 @default.
- W2587882014 hasRelatedWork W2965474825 @default.
- W2587882014 hasRelatedWork W2974733069 @default.
- W2587882014 hasRelatedWork W3030454118 @default.
- W2587882014 hasRelatedWork W4234660475 @default.
- W2587882014 hasVolume "69" @default.
- W2587882014 isParatext "false" @default.
- W2587882014 isRetracted "false" @default.
- W2587882014 magId "2587882014" @default.
- W2587882014 workType "article" @default.